BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 2nd Quarter - Report

WYETH PHARMACEUTICALS

via BGR GOVERNMENT AFFAIRS

2nd Quarter (Apr 1 - June 30) · 2008Posted Jul 18, 2008Filing document ↗LDA record ↗

Income$50Kfee reported

Client

Name: WYETH PHARMACEUTICALS
Description: Pharmaceuticals.
Location: * Undetermined

Registrant

Firm: BGR GOVERNMENT AFFAIRS
Description: Lobbying firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Medicare part-D formularies; comparative effectiveness; Medicare formulary
LobbyistsMARY LACEY REUTHER · ROBERT WOOD · SHALLA ROSS · JENNIFER LARKIN LUKAWSKI
Covered position (MARY LACEY REUTHER): See prior filing.
Covered position (ROBERT WOOD): See prior filing.
Covered position (SHALLA ROSS): See prior filing.
Covered position (JENNIFER LARKIN LUKAWSKI): See prior filing.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

WYETH PHARMACEUTICALS — Lobbying — Receipts Report